Table 4.
Logistic regression models of metabolic syndrome (MetS) status in subjects
| Model 1 | Model 2 | |||||
|---|---|---|---|---|---|---|
| Covariate | OR (95% CI) | P value | Covariate | OR (95% CI) | P value | |
| Male: | ||||||
| ATP III-A | Outpatients | 7.569 (4.829 to 11.863) | < 0.001 | Outpatients | 3.664 (2.187 to 6.139) | < 0.001 |
| Age | 1.000 (0.985 to 1.015) | NS | Age | 1.015 (0.998 to 1.036) | NS | |
| BMI | 1.479 (1.365 to 1.602) | < 0.001 | ||||
| IDF | Outpatients | 6.717 (4.188 to 10.7765) | < 0.001 | Outpatients | 2.506 (1.397 to 4.496) | < 0.01 |
| Age | 0.998 (0.983 to 1.014) | NS | Age | 1.018 (0.996 to 1.040) | NS | |
| BMI | 1.677 (1.517 to 1.855) | < 0.001 | ||||
| JASSO | Outpatients | 6.071 (3.795 to 9.711) | < 0.001 | Outpatients | 2.599 (1.505 to 4.488) | < 0.01 |
| Age | 1.011 (0.995 to 1.027) | NS | Age | 1.034 (1.014 to 1.055) | < 0.01 | |
| BMI | 1.467 (1.354 to 1.589) | < 0.001 | ||||
| Female: | ||||||
| ATP III-A | Outpatients | 4.243 (2.699 to 6.671) | < 0.001 | Outpatients | 2.477 (1.474 to 4.161) | < 0.01 |
| Age | 1.017 (1.002 to 1.032) | < 0.05 | Age | 1.032 (1.013 to 1.050) | < 0.01 | |
| BMI | 1.332 (1.253 to 1.416) | < 0.001 | ||||
| IDF | Outpatients | 3.952 (2.497 to 6.254) | < 0.001 | Outpatients | 2.842 (1.738 to 4.647) | < 0.001 |
| Age | 1.015 (1.000 to 1.030) | NS | Age | 1.021 (1.004 to 1.038) | < 0.05 | |
| BMI | 1.143 (1.090 to 1.198) | < 0.001 | ||||
| JASSO | Outpatients | 5.655 (2.923 to 10.940) | < 0.001 | Outpatients | 4.137 (2.047 to 8.361) | < 0.001 |
| Age | 1.010 (0.989 to 1.031) | NS | Age | 1.012 (0.990 to 1.035) | NS | |
| BMI | 1.089 (1.027 to 1.154) | < 0.01 | ||||
ATP III-A = Adapted National Cholesterol Education Program Adult Treatment Panel; BMI = body mass index; IDF = International Diabetes Federation; JASSO = Japan Society for the Study of Obesity; OR = odds ratio; NS = not significant.